Stifel on Exact Sciences (EXAS): 'CDLT Rate Up 16% for Cologuard Plus; A Stab At What That Means for FY25 ASP'
Tweet Send to a Friend
Stifel analyst Daniel Arias reiterated a Buy rating and $67.00 price target on Exact Sciences (NASDAQ: EXAS).The analyst comments "CDLT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
